Article
30 Sep 2026
Seventh Circuit Holds ERISA Does Not Preempt Arkansas PBM Regulation
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
20 Jul 2026
FTC Reaches Second Insulin Pricing Settlement: Comparing The Caremark And ESI Orders
Article
25 Jun 2026
Inflation Reduction Act Update: What’s Changing In Drug Pricing
Article
13 May 2026
DOL’s Proposed PBM Fee Disclosure Rule: Key Themes From The Public Comments
Article
24 Apr 2026
PBM Policy And Legislative Update — Spring 2026
Article
23 Mar 2026
PBM Reform 2026: What Recent Legislation Means For The Industry (Video)
Article
13 Feb 2026
What PBMs And Group Health Plans Need To Know About The Department Of Labor's Proposed PBM Fee Disclosure Rule
Article
12 Feb 2026
Congress Passes Landmark PBM Reform In 2026 Spending Bill
Article
28 Jan 2026
Understanding California SB-41: What PBMs Operating In California Need To Know
Article
07 Jan 2026
The BALANCE Model And A New Wave Of CMS Drug Pricing Models
Article
30 Dec 2025
Pharmaceutical Policy In Motion Continued: Trump Inks Nine New Drug Pricing Deals
Article
30 Dec 2025
CMS Targets Rising Drug Costs With New Guard And Globe Pilot Programs
Article
19 Nov 2025
Pharmaceutical Policy In Motion: Updates On The Trump Administration's Drug Pricing Initiatives
Article
11 Nov 2025
Filling The Gaps And Navigating Fine Lines: Regulatory Compliance Framework And Considerations For California Medical Spas
Article
21 Oct 2025
Understanding California SB-41: What PBMs Operating In California Need To Know
Article
16 Oct 2025
This Time, California Governor Newsom Signs Private Equity Group And Hedge Fund Bills
Article
24 Sep 2025
Health Law Diagnosed: Mintz IRA Update — Q3 2025 Edition (Podcast)
Article
22 Sep 2025
Mintz IRA Update — The Uncertain State Of Affairs For GLP-1s
Article
22 Sep 2025
Mintz IRA Update — Medicare Part B Physician Fee Schedule Guidance And Its Potential Implications For Medicare Part D
Article
18 Sep 2025
Mintz IRA Update — PhRMA's 2025 Policy Agenda And The Industry's Crossroads With The IRA And Drug Pricing Reform